Current Status
Not Enrolled
Price
Free
Get Started
Course
Resources
Information

Suspecting ATTR Amyloidosis

Program: Suspecting and Diagnosing ATTR Amyloidosis
To obtain CME/CE credit, you must LOG-IN and ENROLL (click orange button at top of page)

Jointly Provided by

CheckRare
Support for this activity has been made possible through educational grants from Akcea Therapeutics and Alnylam Pharmaceuticals.

Release date: 07/20/20
Expiration date: 07/31/21
Estimated time to complete: 0.25 hours

Activity Description

Amyloid transthyretin (ATTR) amyloidosis is a rare form of amyloidosis. The most dominant organ usually impacted by amyloidosis is the heart, but it can also impact other organs, including the nervous system. Many clinicians who see these patients before they are diagnosed will not be aware of ATTR amyoidosis, nor when to suspect it and how to diagnose this rare condition. On average it takes 2 – 4 years for this treatable condition to be properly diagnosed.

This CME/CNE activity is designed to assist clinicians in identifying factors which suggest the need to explore a possible diagnosis of ATTR amyloidosis.

Activity Faculty

Morie A Gertz, MD, MACP
Consultant – Division of Hematology, Department of Internal Medicine
Mayo Clinic
Professor of Medicine
Mayo Clinic College of Medicine and Science
Rochester, Minnesota

Target Audience

This activity has been designed to meet the educational needs of physicians, nurses, and nurse practitioners likely to interact with individuals who may have ATTR amyloidosis.

Learning Objectives

After participating in the activity, learners should be better able to:

  • Identify factors which suggest the need to explore a possible diagnosis of ATTR amyloidosis

Accreditation and Credit Designation

In support of improving patient care, this activity has been planned and implemented by American Academy of CME, Inc. and CheckRare CE. American Academy of CME, Inc. is Jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians
American Academy of CME, Inc., designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses
American Academy of CME, Inc designates this enduring material for a maximum of 0.25 ANCC contact hours.

Other members of the care team will receive a certificate of participation.

Disclosure Statement

According to the disclosure policy of the Academy, all faculty, planning committee members, editors, managers and other individuals who are in a position to control content are required to disclose any relevant relationships with any commercial interests related to this activity. The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation. All educational materials are reviewed for fair balance, scientific objectivity and levels of evidence. Disclosures are as follows:

Dr. Gertz has the following relationships to disclose:

  • Advisory Board for Marketing Purposes: Ionis/Akcea, Alnylam, Prothena, Annexon, Amgen, Sanofi
  • Advisory Board for Scientific Information: AbbVie, Celgene
  • Shareholder: Aurora Bio

Planners for this activity have no relevant financial relationships with any commercial interests.

This activity will review off-label or investigational information.

The opinions expressed in this educational activity are those of the faculty, and do not represent those of the Academy or CheckRare CE. This activity is intended as a supplement to existing knowledge, published information, and practice guidelines. Learners should appraise the information presented critically, and draw conclusions only after careful consideration of all available scientific information.

Method of Participation

There are no fees to participate in the activity. Participants must review the activity information including the learning objectives and disclosure statements, as well as the content of the activity. To receive CME/CNE credit for your participation, please complete the post-program assessment. Your certificate can be mailed to you in approximately 30 days.

Hardware/Software Requirements

Windows Requirements: • Operating system: Windows XP Service Pack 2 or later • Browser: Internet Explorer 7 or later, Mozilla Firefox 2.5 or later • Internet connection: DSL, cable modem, or other high-speed connection

Macintosh Requirements: • Operating system: Mac OS X v10.3 or later • Browser: Mozilla Firefox 2.5 or later • Internet connection: DSL, cable modem, or other high-speed connection

Privacy

For more information about the American Academy of CME privacy policy, please access http://www.academycme.org/privacy.htm. For more information about CheckRare’s privacy policy, please access https://checkrare.com/privacy/

Contact

For any questions, please contact: CEServices@academycme.org

Copyright

© 2020. This CME/CNE-certified activity is held as copyrighted © by American Academy of CME and CheckRare CE. Through this notice, the Academy and CheckRare grant permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).

Suspecting ATTR Amyloidosis

Program: Suspecting and Diagnosing ATTR Amyloidosis

Suspecting ATTR Amyloidosis

Program: Suspecting and Diagnosing ATTR Amyloidosis

Jointly Provided by

CheckRare
Support for this activity has been made possible through educational grants from Akcea Therapeutics and Alnylam Pharmaceuticals.

Release date: 07/20/20
Expiration date: 07/31/21
Estimated time to complete: 0.25 hours

Activity Description

Amyloid transthyretin (ATTR) amyloidosis is a rare form of amyloidosis. The most dominant organ usually impacted by amyloidosis is the heart, but it can also impact other organs, including the nervous system. Many clinicians who see these patients before they are diagnosed will not be aware of ATTR amyoidosis, nor when to suspect it and how to diagnose this rare condition. On average it takes 2 – 4 years for this treatable condition to be properly diagnosed.

This CME/CNE activity is designed to assist clinicians in identifying factors which suggest the need to explore a possible diagnosis of ATTR amyloidosis.

Activity Faculty

Morie A Gertz, MD, MACP
Consultant - Division of Hematology, Department of Internal Medicine
Mayo Clinic
Professor of Medicine
Mayo Clinic College of Medicine and Science
Rochester, Minnesota

Target Audience

This activity has been designed to meet the educational needs of physicians, nurses, and nurse practitioners likely to interact with individuals who may have ATTR amyloidosis.

Learning Objectives

After participating in the activity, learners should be better able to:

  • Identify factors which suggest the need to explore a possible diagnosis of ATTR amyloidosis

Accreditation and Credit Designation

In support of improving patient care, this activity has been planned and implemented by American Academy of CME, Inc. and CheckRare CE. American Academy of CME, Inc. is Jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians
American Academy of CME, Inc., designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses
American Academy of CME, Inc designates this enduring material for a maximum of 0.25 ANCC contact hours.

Other members of the care team will receive a certificate of participation.

Disclosure Statement

According to the disclosure policy of the Academy, all faculty, planning committee members, editors, managers and other individuals who are in a position to control content are required to disclose any relevant relationships with any commercial interests related to this activity. The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation. All educational materials are reviewed for fair balance, scientific objectivity and levels of evidence. Disclosures are as follows:

Dr. Gertz has the following relationships to disclose:

  • Advisory Board for Marketing Purposes: Ionis/Akcea, Alnylam, Prothena, Annexon, Amgen, Sanofi
  • Advisory Board for Scientific Information: AbbVie, Celgene
  • Shareholder: Aurora Bio

Planners for this activity have no relevant financial relationships with any commercial interests.

This activity will review off-label or investigational information.

The opinions expressed in this educational activity are those of the faculty, and do not represent those of the Academy or CheckRare CE. This activity is intended as a supplement to existing knowledge, published information, and practice guidelines. Learners should appraise the information presented critically, and draw conclusions only after careful consideration of all available scientific information.

Method of Participation

There are no fees to participate in the activity. Participants must review the activity information including the learning objectives and disclosure statements, as well as the content of the activity. To receive CME/CNE credit for your participation, please complete the post-program assessment. Your certificate can be mailed to you in approximately 30 days.

Hardware/Software Requirements

Windows Requirements: • Operating system: Windows XP Service Pack 2 or later • Browser: Internet Explorer 7 or later, Mozilla Firefox 2.5 or later • Internet connection: DSL, cable modem, or other high-speed connection

Macintosh Requirements: • Operating system: Mac OS X v10.3 or later • Browser: Mozilla Firefox 2.5 or later • Internet connection: DSL, cable modem, or other high-speed connection

Privacy

For more information about the American Academy of CME privacy policy, please access http://www.academycme.org/privacy.htm. For more information about CheckRare's privacy policy, please access https://checkrare.com/privacy/

Contact

For any questions, please contact: CEServices@academycme.org

Copyright

© 2020. This CME/CNE-certified activity is held as copyrighted © by American Academy of CME and CheckRare CE. Through this notice, the Academy and CheckRare grant permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).

  • Sign up
Lost your password? Please enter your username or email address. You will receive a link to create a new password via email.
We do not share your personal details with anyone.